tourette

12 items

January 11, 2023

Emalex Biosciences Publishes Phase 2b Results for Tourette Syndrome Candidate in Pediatrics
– Study data shows investigational new drug, [...]
September 1, 2020

Emalex Biosciences Phase 2b Tourette Syndrome Clinical Trial Reaches Enrollment Milestone
– Half of participants are now enrolled [...]
June 3, 2020

Horizon Technology Finance and Emalex Biosciences Announce $15 Million Venture Loan Facility
– Biopharmaceutical company advancing clinical research evaluating novel [...]
August 14, 2018

Emalex Biosciences Acquires Psyadon Pharmaceuticals to Develop Novel Treatment for Pediatric Tourette Syndrome
CHICAGO – August 14, 2018 – Biopharmaceutical company [...]